EP Patent

EP3287122B1 — Device for storage and administration of topical oxybutynin compositions for treating overactive bladders.

Assigned to Allergan Sales LLC · Expires 2019-04-17 · 7y expired

What this patent protects

Patent listed against oxybutynin-chloride.

Drugs covered by this patent

oxybutynin-chloride (OXYBUTYNIN CHLORIDE)

Patent Metadata

Patent number: EP3287122B1
Jurisdiction: EP
Classification: —
Expires: 2019-04-17
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Sales LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.